Related references
Note: Only part of the references are listed.MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway
Yang Lei et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-β1 mediated epithelial-mesenchymal transition in hepatocytes
Yanting Zou et al.
CELLULAR SIGNALLING (2019)
Schisandrin B Attenuates Inflammation in LPS-Induced Sepsis Through miR-17-5p Downregulating TLR4
Zhi-Rong Ji et al.
INFLAMMATION (2019)
MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation
Ying-Hsien Huang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
MicroRNA-351 promotes schistosomiasis-induced hepatic fibrosis by targeting the vitamin D receptor
Xing He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Qiaozhu Su et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
Jorge Matias Caviglia et al.
HEPATOLOGY (2018)
MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling
Kai You et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis
Le Tao et al.
ARCHIVES OF TOXICOLOGY (2018)
MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction
Yue Zhou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Schisandrin B inhibits the proliferation and invasion of glioma cells by regulating the HOTAIR- micoRNA-125a-mTOR pathway
Yan Jiang et al.
NEUROREPORT (2017)
Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways
Qingshan Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Schisandrin B inhibits the proliferation of airway smooth muscle cells via microRNA-135a suppressing the expression of transient receptor potential channel 1
Xiao-yu Zhang et al.
CELL BIOLOGY INTERNATIONAL (2016)
MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
Jeongeun Hyun et al.
NATURE COMMUNICATIONS (2016)
Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson's disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway
Qinghua Ba et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis
Fujun Yu et al.
CELL CYCLE (2015)
MicroRNA-101a Inhibits Cardiac Fibrosis Induced by Hypoxia via Targeting TGF beta RI on Cardiac Fibroblasts
Xin Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: A review of the molecular mechanisms
Jung Nyeo Chun et al.
FITOTERAPIA (2014)
MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway
Xiaolong Tu et al.
JOURNAL OF PATHOLOGY (2014)
Evolving therapies for liver fibrosis
Detlef Schuppan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway
Zhenwei Pan et al.
CIRCULATION (2012)
Fibrosis-dependent mechanisms of hepatocarcinogenesis
David Y. Zhang et al.
HEPATOLOGY (2012)
Micro-RNA Profiling Reveals a Role for miR-29 in Human and Murine Liver Fibrosis
Christoph Roderburg et al.
HEPATOLOGY (2011)
MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
Hang Su et al.
CANCER RESEARCH (2009)
Share Paper
